STOCK TITAN

Pharma-Bio Serv Inc - PBSV STOCK NEWS

Welcome to our dedicated news page for Pharma-Bio Serv (Ticker: PBSV), a resource for investors and traders seeking the latest updates and insights on Pharma-Bio Serv.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Pharma-Bio Serv's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Pharma-Bio Serv's position in the market.

Rhea-AI Summary
Pharma-Bio Serv, Inc. announced a decrease in revenues for the year ended October 31, 2023, but an improvement in net income. The company's overall gross profit improved by 4.6 percentage points compared to last year. The CEO highlighted the strategy of exploiting opportunities in new markets and pursuing robust opportunities in targeted markets to achieve external growth and maximize shareholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.95%
Tags
none
-
Rhea-AI Summary
Pharma-Bio Serv, Inc. (PBSV) announces approval of Special Dividend of $0.075 per share for Shareholders
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.89%
Tags
dividends
-
Rhea-AI Summary
Pharma-Bio Serv reports increase in net income and gross profit margin for Q3 2023. Revenues decrease compared to last year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.7%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.55%
Tags
dividends
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.24%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Pharma-Bio Serv Inc

OTC:PBSV

PBSV Rankings

PBSV Stock Data

21.13M
8.43M
64.76%
Testing Laboratories
Professional, Scientific, and Technical Services
Link
United States
Dorado

About PBSV

pharma-bio serv is the life sciences industry leader in regulatory compliance, validation, and other regulated industry support services. founded in february 1993, pharma-bio serv offers technical services, product and process transfers, commissioning, process engineering, and technology transfer, to pharmaceutical, medical devices, consumer, chemical and biotechnology industries in puerto rico, united states, brazil and europe. our diverse team offers an integrated service structure designed to provide complete solutions for our client needs. following this holistic approach, we diversified our services with new divisions to support our clients: a laboratory testing facility in puerto rico and spain, scienzalabs, offering microbiological and analytical testing services; metrologix, provides a full range of calibration program management solutions, including calibration standard management, annual calibration workload balancing, and scheduling and data entry; integratek, providing it/s